Viewing Study NCT02148133

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-01-24 @ 7:00 PM
Study NCT ID: NCT02148133
Status: COMPLETED
Last Update Posted: 2019-05-03
First Post: 2014-05-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cytopaenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Eltrombopag View
None Aplastic Anemia (AA) View
None Thrombocytopenia View
None Thrombopoietin View
None Bone Marrow View
None Bone Marrow Biopsy View
None Hematopoietic Stem Cells View
None Mature Blood Cells View
None Pancytopenia View
None Leukopenia View
None Platelets View